Intellectual property and nanopharmaceuticals

• Tipo: Capítulo ou Parte de Livro
• Data: 2012

Autores

Puthli, SP (Autor) Outra; Puthli, MS (Autor) Outra; Macedo, AS (Autor) Outra; Souto, EB (Autor) Outra

Livro

Título: Patenting Nanomedicines: Legal Aspects, Intellectual Property and Grant Opportunities

Páginas: 3-24

ISBN: 9783642292651; 364229264X; 9783642292644

Editora: Springer Berlin Heidelberg

Indexação

Scopus - 1 Citação

Outras Informações

ID Authenticus: P-00K-1TT

DOI: 10.1007/978-3-642-29265-1_1

Abstract (EN): Nanopharmaceuticals are a promising pathway to overcome traditional therapeutic limitations, since they are formulated to have high affinity to a specific target. These formulations are an improvement of old formulations resulting in better patient compliance. To acquire commercialization rights over a formulation it is necessary to patent the invention. Patenting an invention is crucial for nanomedicine evolution. The significance of intellectual property in this field has led to many startup companies to patent their technology. Licensing agreements have been one of the important options for many entrepreneurs with suitable benefit to both the parties. Due to initiatives taken by government (like implementation of the Bayh Dole Act, in the USA), the industry-academia collaborative research activities have increased to a large extent. © 2012 Springer-Verlag Berlin Heidelberg. All rights are reserved.

Idioma: Inglês

Tipo (Avaliação Docente): Científica